Medical Condition News

RSS

Research provides insight into brain reorganization following sensory loss

The part of the brain that uses hearing to determine sound location is reorganized in deaf animals to locate visual targets, according to a new study by a team of researchers from Virginia Commonwealth University and the University of Western Ontario in Canada.

11 May 2011

Reducing hearing aid cost does not improve device purchase

Lowering the cost of hearing aids isn't enough to motivate adults with mild hearing loss to purchase a device at a younger age or before their hearing worsens, according to researchers at Henry Ford Hospital.

11 May 2011

Insight into probiotic bacteria can help improve intestinal disease treatments

The gut may need bacteria to provide a little bit of oxidative stress to stay healthy, new research suggests. Probiotic bacteria promote healing of the intestinal lining in mice by inducing the production of reactive oxygen species, researchers at Emory University School of Medicine have shown.

11 May 2011

Study stresses importance of rapid intervention to prevent Self-Embedding Behavior in adolescents

While the disturbing act of self-injury is nothing new to adolescents, researchers and physicians at Nationwide Children's Hospital have identified a more severe type of behavior that is raising some concern among medical professionals.

11 May 2011

Intensive exercise can help improve facial nerve damage

A research study conducted at Washington State University Spokane offers hope to those suffering from facial nerve damage. According to the study, which was published online this week in the journal Developmental Neurohabilitation, muscle weakness resulting from facial nerve damage incurred during childhood can improve with intensive facial exercise, years after injury.

11 May 2011

Genentech submits vemurafenib NDA for BRAF V600 mutation-positive metastatic melanoma

Genentech, a member of the Roche Group, today announced that the company submitted a New Drug Application for vemurafenib to the U.S. Food and Drug Administration for people with BRAF V600 mutation-positive metastatic melanoma, and that Roche submitted a Marketing Authorization Application to the European Medicines Agency for vemurafenib in the same indication.

11 May 2011

Safety tips for athletes with asthma and allergies

As athletes of all ages take the field this summer, the most fearsome opponents for those with asthma and allergies might be triggers that can sideline even the toughest competitors.

11 May 2011

Shanghai Zhabei Health Bureau, CWRU sign 10-year research deal to study Chinese lifestyle

Case Western Reserve University School of Medicine has signed an unprecedented 10-year research agreement with the Shanghai Zhabei District Health Bureau to study how an increasingly westernized diet and a less active lifestyle are affecting the health of China's residents.

11 May 2011

Scleroderma is an independent determinant for coronary calcification, study suggests

A new study by researchers in Hong Kong suggests that systemic sclerosis is an independent determinant for moderate to severe coronary calcification or atherosclerosis.

11 May 2011

Depressed patients with chronic illnesses less likely to adhere to medications

People who are depressed are less likely to adhere to medications for their chronic health problems than patients who are not depressed, putting them at increased risk of poor health, according to a new RAND Corporation study.

11 May 2011

Plexxikon seeks vemurafenib marketing approval from FDA and EMA for melanoma treatment

Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced that applications for market approval for vemurafenib for the treatment of metastatic melanoma have been submitted to the U.S. Food and Drug Administration and the European Medicines Agency.

11 May 2011

Zebrafish research identifies undiscovered high-risk genetic features in T-cell acute lymphocytic leukemia

Leukemia is the most common childhood cancer; it also occurs in adults. Now researchers working with zebrafish at Huntsman Cancer Institute (HCI) at the University of Utah have identified previously undiscovered high-risk genetic features in T-cell acute lymphocytic leukemia (T-ALL), according to an article published online May 9, 2011, in the cancer research journal Oncogene.

11 May 2011

$Study: Only 15% of heart failure patients with spinal fractures are being treated for osteoporosis$

Study: Only 15% of heart failure patients with spinal fractures are being treated for osteoporosis

One in 10 heart failure patients had compression fractures in the spine that could have been detected by a chest X-ray, but few are receiving treatment to help prevent such fractures according to a Canadian study published in the American Heart Association journal Circulation: Heart Failure.

11 May 2011

Second subject enrolled in human embryonic stem cell therapy trial for subacute thoracic spinal cord injury

Researchers at Northwestern Memorial Hospital, Northwestern University Feinberg School of Medicine and The Rehabilitation Institute of Chicago (RIC) recently enrolled their first subject in a national clinical research trial of a human embryonic stem cell-based therapy for participants with a subacute thoracic spinal cord injury.

11 May 2011

Protein critical to formation of new blood vessels could lead to therapies to starve cancerous tumors

UT Southwestern Medical Center researchers have discovered a protein that guides blood vessel development and eventually might lead to a treatment to keep cancer cells from spreading.

11 May 2011

Scientists unravel how genetic defects can help predict risk of sudden cardiac death

Sudden cardiac death is always a shocking, tragic event, especially when it occurs at a young age. But, for the first time, scientists are unraveling how genetic defects can help predict the risk of dying suddenly in individuals with one of the leading causes of this unfortunate phenomenon.

11 May 2011

Couples having marital difficulties may have infants with sleep problems

Couples having marital difficulties may have infants who are losing sleep, according to a new study - and that may have a continuing impact on the children.

11 May 2011

16-year-old uses supercomputing network to invent new drug cocktail for cystic fibrosis

While many 16-year-olds are content with PlayStation, Toronto-area student Marshall Zhang used the Canadian SCINET supercomputing network to invent a new drug cocktail which could one day help treat cystic fibrosis.

11 May 2011

Long non-coding RNA promotes melanoma cell survival and invasion

Traditionally, RNA was mostly known as the messenger molecule that carries protein-making instructions from a cell's nucleus to the cytoplasm. But scientists now estimate that approximately 97 percent of human RNA doesn't actually code for proteins at all. A flurry of research in the past decade has revealed that some types of non-coding RNAs switch genes on and off and influence protein function.

11 May 2011

NCL launches new public education campaign on medication adherence

Today the National Consumers League launches a new public education campaign, Script Your Future, to raise awareness among patients about the consequences of not taking medication as directed.

11 May 2011

Medical Condition News

Research provides insight into brain reorganization following sensory loss

Reducing hearing aid cost does not improve device purchase

Insight into probiotic bacteria can help improve intestinal disease treatments

Study stresses importance of rapid intervention to prevent Self-Embedding Behavior in adolescents

Intensive exercise can help improve facial nerve damage

Genentech submits vemurafenib NDA for BRAF V600 mutation-positive metastatic melanoma

Safety tips for athletes with asthma and allergies

Shanghai Zhabei Health Bureau, CWRU sign 10-year research deal to study Chinese lifestyle

Scleroderma is an independent determinant for coronary calcification, study suggests

Depressed patients with chronic illnesses less likely to adhere to medications

Plexxikon seeks vemurafenib marketing approval from FDA and EMA for melanoma treatment

Zebrafish research identifies undiscovered high-risk genetic features in T-cell acute lymphocytic leukemia

Study: Only 15% of heart failure patients with spinal fractures are being treated for osteoporosis

Second subject enrolled in human embryonic stem cell therapy trial for subacute thoracic spinal cord injury

Protein critical to formation of new blood vessels could lead to therapies to starve cancerous tumors

Scientists unravel how genetic defects can help predict risk of sudden cardiac death

Couples having marital difficulties may have infants with sleep problems

16-year-old uses supercomputing network to invent new drug cocktail for cystic fibrosis

Long non-coding RNA promotes melanoma cell survival and invasion

NCL launches new public education campaign on medication adherence

CoppaFeel!: Breast Cancer Doesn’t Discriminate, So Why Should Awareness?

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Latest News